AF
CSTL icon

Allworth Financial’s Castle Biosciences CSTL Stock Holding History

Allworth Financial’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55K Buy
63
+33
+110% +$1.08K ﹤0.01% 4432
2025
Q4 		$1.17K Buy
30
+11
+58% +$355 ﹤0.01% 4315
2025
Q3 		$433 Buy
19
+14
+280% +$284 ﹤0.01% 4473
2025
Q2 		$103 Buy
+5
New +$93 ﹤0.01% 4397
2023
Q4 		– Sell
-41
Closed -$693 – 3494
2023
Q3 		$693 Sell
41
-33
-45% -$577 ﹤0.01% 2959
2023
Q2 		$1.02K Sell
74
-57
-44% -$1.16K ﹤0.01% 2729
2023
Q1 		$2.98K Buy
131
+123
+1,538% +$3K ﹤0.01% 2242
2022
Q4 		$188 Hold
8
– – ﹤0.01% 2795
2022
Q3 		$0 Hold
8
– – ﹤0.01% 2735
2022
Q2 		$0 Buy
+8
New +$186 ﹤0.01% 2469

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allworth Financial's CSTL Position: Q1 2026 in Review

Allworth Financial increased its Castle Biosciences (CSTL) stake by 110% in Q1 2026, buying an estimated $1.08K and bringing the position to 63 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #4432.

Allworth Financial first reported a position in CSTL in Q2 2022 and has held it in 10 quarters since. The position peaked at $2.98K in Q1 2023. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Allworth Financial held 63 shares of Castle Biosciences worth $1.55K as of Q1 2026.
  • Allworth Financial bought 33 Castle Biosciences shares in Q1 2026, an estimated $1.08K.
  • Castle Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4432 holding.
  • Allworth Financial first reported a position in Castle Biosciences in Q2 2022 and has held it in 10 quarters since.
  • Allworth Financial's Castle Biosciences position peaked at $2.98K in Q1 2023.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.